In vitro dissolution profile comparison--statistics and analysis of the similarity factor, f2.

Office of Pharmaceutical Science, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852, USA.
Pharmaceutical Research (Impact Factor: 4.74). 07/1998; 15(6):889-96. DOI: 10.1023/A:1011976615750
Source: PubMed

ABSTRACT To describe the properties of the similarity factor (f2) as a measure for assessing the similarity of two dissolution profiles. Discuss the statistical properties of the estimate based on sample means.
The f2 metrics and the decision rule is evaluated using examples of dissolution profiles. The confidence interval is calculated using bootstrapping method. The bias of the estimate using sample mean dissolution is evaluated.
1. f2 values were found to be sensitive to number of sample points, after the dissolution plateau has been reached. 2. The statistical evaluation of f2 could be made using 90% confidence interval approach. 3. The statistical distribution of f2 metrics could be simulated using 'Bootstrap' method. A relatively robust distribution could be obtained after more than 500 'Bootstraps'. 4. A statistical 'bias correction' was found to reduce the bias.
The similarity factor f2 is a simple measure for the comparison of two dissolution profiles. But the commonly used similarity factor estimate f2 is a biased and conservative estimate of f2. The bootstrap approach is a useful tool to simulate the confidence interval.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The objective of present work was to construct nomogram for obtaining a value of similarity factor (f2) by employing the values of number of observations (n) and sum of squared difference of percentage drug dissolved between reference (R) and test (T) products . The steps for rearrangement of equation of similarity factor are presented. The values of f2 were selected in the range of 45 to 100 for 4 to 12 observations (n) for computing the values of Linear regression analysis was performed between number of observations and . Perfect correlation was observed in each case. Nomogram was constructed and later it was validated by using drug dissolution data from literature and our laboratory. The use of nomogram is recommended during research and development work to investigate effect of formulation or process variables. The nomogram can also be used during change in manufacturing site or change in equipment. It is concluded that the steps for calculation of f2 can be truncated in the middle (i.e. at the step of calculation of factor and a decision of similarity/dissimilarity can be taken employing the nomogram.
    Indian Journal of Pharmaceutical Sciences 05/2014; 76(3):245-51. · 0.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: AimThe main aim of this study was to prepare and evaluate once daily sustained release tablets of aceclofenac by using polyethylene oxides (PEOs) of different molecular weights as matrix polymers.MethodA direct compression method was used to prepare PEO matrices. Type and the amount of PEO in the matrices were varied to optimize in vitro aceclofenac release profiles.ResultsFrom the in vitro release studies, it was found that the matrix tablets containing 28% of PEO (80% PEO WSR 303 and 20% of PEO WSR N60K) showed similar release profiles, as estimated by similarity factor (f2), to a marketed product, Hifenac SR.From the bioavailability study in human volunteers, it was found that there was no statistically significant difference in the pharmacokinetic parameters such as Tmax and Cmax between the optimized sustained release formulation containing 28% of PEO and Hifenac SR.Conclusion It can be concluded from this study, that the bioavailability of the sustained release formulation developed was similar to that of Hifenac SR and the hydrophilic PEO matrices are novel sustained release carriers for the delivery of aceclofenac.
    Journal of Pharmacy Research. 02/2013; 6(2):249–254.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aims of the present study were to prepare hydroxypropylmethyl cellulose-based matrix tablets prepared using the freeze-drying method for gastroretentive delivery of ecabet sodium (ECS), a locally acting antigastric ulcer drug, and to perform in vitro/in vivo characterizations. The freeze-dried gastroretentive tablets (FD-GRTs) had porous structures, while they had good friability as a pharmaceutical dosage form. The porous structures lowered the tablet density, allowing the tablet to float without any lag time. Buoyancy of FD-GRT was maintained until they were entirely disintegrated during an in vitro release study. Release rate of ECS could be controlled by the amount of ethylcellulose (EC) in FD-GRT. As amount of EC in the composition was increased, there was a decrease in both release rate and erosion rate of FD-GRT. When administered to a miniature pig, FD-GRT remained in the stomach for more than 12 h, which was significantly longer than a conventional sustained release tablet. The new FD-GRT do not contain any excipients for buoyancy and do not require any lag time for buoyancy, consequently it could be considered to be safer and more effective than conventional floating-type GRT. © 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 103:262–273, 2014
    Journal of Pharmaceutical Sciences 01/2014; 103(1). · 3.13 Impact Factor